IGF-1 is the Insulin-Like Growth Factor 1 or Somatomedin 1 and is naturally present in the blood. It is a polypeptide hormone that has structural similarity to Insulin. It is primarily synthesized in the liver, and its synthesis is managed by the pituitary secretion of Growth Hormone (GH). Many other organs like the brain also synthesize IGF-1 locally.
The primary function of IGF-1 is the stimulation of growth. Most tissues, including bone, undergo hypertrophy, an increase in cell size, and hyperplasia, which means an increase in cell number due to the secretion of IGF-1.
The concentration of IGF-1 in serum increases during childhood and it is at its peak during puberty. After puberty, it decreases progressively. Researchers have shown that IGF-1 is undetectable in people over the age of 60. Such research studies have led to numerous theories which say that the upregulation of IGF-1 may delay aging.
Numerous research studies have validated that decreasing levels of IGF-1 play an important role in the negative effects linked with the aging process, including a decline in lean muscle mass and an increase in adipose (fat) tissue. One research of 21 healthy men aged 61 to 81 merely adds to the growing body of evidence showing low IGF-1 levels in the body are closely linked to an increase in the negative consequences of aging.
The males were split into two groups in the study: one had IGF-1 treatment three times weekly for six months, while the other received no treatment. The effects on the therapy group were as pronounced as they were convinced by the end of the research. This group experienced an 8.8% gain in lean muscle mass and a 14.4% decrease in adipose tissue. Furthermore, the therapy group experienced an average increase of 1.6 percent in lumbar vertebral bone density and a 7.1 percent rise in skin thickness (thinning of the skin and certain bones is a significant effect of the aging process). On the other hand, the control group experienced no changes in muscle mass, adiposity, bone density, or skin thickness. This and other studies like it abound, highlighting the vital role IGF-1 plays in the body.
Importantly, IGF-1 LR3 peptide is thought to be 2-3 times more effective in generating these effects than unmodified IGF-1. IGF-1 LR3 peptide is a more potent form of IGF-1 that has been chemically changed.
IGF-1 LR3 peptide & muscle growth
IGF-1 LR3 peptide is widely regarded as a potent activator of muscle growth. Many people are still ignorant of how IGF-1 LR3 peptide affects muscular tissue. IGF-1 LR3 peptide promotes new muscle cells and fibers while supporting the growth and retention of existing muscular tissue. IGF-1 LR3 peptide’s capacity to stimulate muscle cell proliferation in addition to its powerful anabolic properties distinguishes it from other muscle-building supplements.
When a person is exposed to certain muscular stimulation, such as that induced by weight training, the body responds by undergoing a process known as hypertrophy, which is an increase in the size of already existing muscle cells. This procedure, crucially, only impacts existing muscle cells. Only the muscle cells already present in the body grow in size; no new muscle cells or fibers are formed. The mature body only has a limited amount of muscle cells that can grow in this way. However, research has shown that giving study participants IGF-1 LR3 peptide, also known as Long R3 IGF-1, causes an increase in the size of existing muscle cells and the formation of new muscle cells (hyperplasia), and the growth of new muscle fibers (mitogenesis). In the presence of IGF-1 LR3 peptide treatment, studies have demonstrated that muscular growth rises considerably, and newly generated muscle cells increase in size and density. Clinical studies have shown that IGF-1 LR3 peptide is one of the few anabolic peptides that can stimulate hyperplasia and mitogenesis, adding even another dimension to its impressive list of actions.
IGF-1 LR3 & growth of new fibers and cells
IGF-1 LR3 peptide stimulates the body’s growth of new fibers and cells. Skin cells are included in this. The development of new skin cells aids in Anti-aging.
According to a clinical experiment conducted by the National Institutes of Health, peptide therapy can reduce the appearance of wrinkles by up to 80%. The peptide was used topically in the trial. A placebo was given to one group, while a peptide-infused formula was given to the other. The depth and intensity of the creases were measured to see if they improved.
The following are the advantages of IGF-1 LR3 peptide therapy:
– Insulin sensitivity is reversed.
– Reduces weight, improves general metabolism, increases energy, accelerates muscular building, and improves sex desire.
– Enhances cognitive function and alleviates sadness
Doctors prescribe this type of peptide therapy to treat a variety of health problems. It aids children with growth problems, as previously stated. It also aids those who have problems growing in other areas, such as those suffering from muscle atrophy. This is especially important for HIV/AIDS patients because the disease causes substantial muscle loss. It can also benefit those who have low bone density.
Disclaimer: The products mentioned are not for human or animal consumption. All the information shared in this article is for educational purposes only.